GSE218060 decitabine T cell 1 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE218060_decitabine_T cell_1_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE218060_decitabine_T cell_1_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE218060_decitabine_T cell_1_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE218060_decitabine_T cell_1_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

family with sequence similarity 30 member A

Gene

HLA complex P5

Gene

cytoskeleton regulator RNA

Gene

Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene

Gene

long intergenic non-protein coding RNA 511

Gene

TP53 target 1

Gene

deleted in lymphocytic leukemia 1

Gene

long intergenic non-protein coding RNA 2910

Gene

uncharacterized LOC339260

Gene

long intergenic non-protein coding RNA 869

  • Gene

    family with sequence similarity 30 member A



  • Gene

    cytoskeleton regulator RNA


  • Gene

    Gfo/Idh/MocA-like oxidoreductase domain containing 3, pseudogene


  • Gene

    long intergenic non-protein coding RNA 511



  • Gene

    deleted in lymphocytic leukemia 1


  • Gene

    long intergenic non-protein coding RNA 2910


  • Gene

    uncharacterized LOC339260


  • Gene

    long intergenic non-protein coding RNA 869

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.